Autolus Therapeutics said it received Food and Drug Administration approval of its treatment of ... Chief Executive Christian Itin said the treatment marks Autolus' first commercial product. In ...
On October 7, 2024, FDA granted marketing authorization for the over‑the‑counter combination flu and COVID-19 combination test, Healgen Rapid ...
If your rapid COVID-19 tests have reached their expiration dates, don't toss them just yet. Here's how to find out if their ...
SHELBY — The Clear Fork Colts had an opportunity to do something no other boys soccer team had ever done in program history. And they took full advantage of it by winning the program's first ...
Team India Saturday suffered their first Test series loss at home since 2012 as their run of 18 consecutive Test series wins at home came to an end. Image: AP New Zealand created cricket history on ...
For all latest news, follow The Daily Star's Google News channel. It is India's first Test series defeat at home since December 2012, when Alastair Cook's England beat them 2-1. Before now New ...
After an eight-wicket loss in the first Test in Bengaluru, India slipped further with a massive 113-run defeat in Pune, succumbing to their first-ever loss at home since November 2012, when they lost ...
Masood, who succeeded Babar Azam as Test captain in 2023, initially faced a 3-0 whitewash by Australia and then a 2-0 home series upset defeat to Bangladesh in August-September 2024. England added to ...
On Friday, Johnson & Johnson (NYSE:JNJ) announced that treatment with Tremfya (guselkumab) resulted in clear or almost clear skin in the ... 13% year over year. Last month, the FDA approved Tremfya ...
Last month, the FDA approved Tremfya for adults with moderately to severely active ulcerative colitis, a chronic disease of the large intestine in which the colon lining becomes inflamed.
Pixclara, a glioma-imaging agent, has been granted priority review by the FDA with a decision deadline of April 26, 2025. The agent targets LAT and LAT2 proteins, aiding in distinguishing glioma ...